Nanomedicine against antimicrobial resistance: mechanistic insights and next-generation therapeutic potential
Vishal L. Handa, Benedict B. Vyas, Abhishek Padhi, Ashwini Agarwal, B. R. M. Vyas · 2026
Read Nanomedicine against antimicrobial resistance: mechanistic insights and next-generation therapeutic potential by Vishal L. Handa, Benedict B. Vyas, Abhishek Padhi, Ashwini Agarwal, B. R. M. Vyas (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13617642.txt.
Description
Handa, Vyas, Padhi, Agarwal, and Vyas review nanomedicine against drug resistant infections in twenty twenty-six. Antimicrobial resistance is a leading global health threat. Germs evade drugs by destroying them, changing targets, or hiding in biofilms. Tiny engineered particles offer another way to attack them.
Nanoparticles can stabilise drugs, aim them at pathogens, and release them slowly. They can also act on several fronts at once. The review covers green synthesis of particles from living sources. It discusses pairing nanomaterials with standard antibiotics to restore their power. Newer platforms include peptide carriers and CRISPR delivery systems. The authors stress that safety, scale up, and regulation still block clinical use.
Catalog record
| CREATOR | Vishal L. Handa, Benedict B. Vyas, Abhishek Padhi, Ashwini Agarwal, B. R. M. Vyas |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |